879 related articles for article (PubMed ID: 22264852)
21. Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study.
Singh G; Fort JG; Goldstein JL; Levy RA; Hanrahan PS; Bello AE; Andrade-Ortega L; Wallemark C; Agrawal NM; Eisen GM; Stenson WF; Triadafilopoulos G;
Am J Med; 2006 Mar; 119(3):255-66. PubMed ID: 16490472
[TBL] [Abstract][Full Text] [Related]
22. Diclofenac potassium liquid-filled soft gelatin capsules in the management of patients with postbunionectomy pain: a Phase III, multicenter, randomized, double-blind, placebo-controlled study conducted over 5 days.
Riff DS; Duckor S; Gottlieb I; Diamond E; Soulier S; Raymond G; Boesing SE
Clin Ther; 2009 Oct; 31(10):2072-85. PubMed ID: 19922878
[TBL] [Abstract][Full Text] [Related]
23. Safety advantages of topical versus oral nonsteroidal antiinflammatory drugs.
Altman RD
J Rheumatol; 2011 Mar; 38(3):572; author reply 573. PubMed ID: 21362791
[No Abstract] [Full Text] [Related]
24. Effect of a topical diclofenac solution for relieving symptoms of primary osteoarthritis of the knee: a randomized controlled trial.
Bookman AA; Williams KS; Shainhouse JZ
CMAJ; 2004 Aug; 171(4):333-8. PubMed ID: 15313991
[TBL] [Abstract][Full Text] [Related]
25. Topical diclofenac versus placebo: a double blind, randomized clinical trial in patients with osteoarthritis of the knee.
Grace D; Rogers J; Skeith K; Anderson K
J Rheumatol; 1999 Dec; 26(12):2659-63. PubMed ID: 10606379
[TBL] [Abstract][Full Text] [Related]
26. Pooled safety analysis of diclofenac sodium topical solution 1.5% (w/w) in the treatment of osteoarthritis in patients aged 75 years or older.
Roth SH; Fuller P
Clin Interv Aging; 2012; 7():127-37. PubMed ID: 22791985
[TBL] [Abstract][Full Text] [Related]
27. A long-term, open-label study to confirm the safety of topical diclofenac solution containing dimethyl sulfoxide in the treatment of the osteoarthritic knee.
Shainhouse JZ; Grierson LM; Naseer Z
Am J Ther; 2010; 17(6):566-76. PubMed ID: 20216203
[TBL] [Abstract][Full Text] [Related]
28. Time to significant pain reduction following DETP application vs placebo for acute soft tissue injuries.
Yanchick J; Magelli M; Bodie J; Sjogren J; Rovati S
Curr Med Res Opin; 2010 Aug; 26(8):1993-2002. PubMed ID: 20575621
[TBL] [Abstract][Full Text] [Related]
29. Short-term treatment with topical diclofenac epolamine plaster in patients with symptomatic knee osteoarthritis: pooled analysis of two randomised clinical studies.
Brühlmann P; de Vathaire F; Dreiser RL; Michel BA
Curr Med Res Opin; 2006 Dec; 22(12):2429-38. PubMed ID: 17257457
[TBL] [Abstract][Full Text] [Related]
30. A comparative subjective assessment study of PENNSAID® and Voltaren Gel®, two topical formulations of diclofenac sodium.
Galer BS
Pain Pract; 2011; 11(3):252-60. PubMed ID: 20854305
[TBL] [Abstract][Full Text] [Related]
31. The hepatic safety and tolerability of the cyclooxygenase-2 selective NSAID celecoxib: pooled analysis of 41 randomized controlled trials.
Soni P; Shell B; Cawkwell G; Li C; Ma H
Curr Med Res Opin; 2009 Aug; 25(8):1841-51. PubMed ID: 19530981
[TBL] [Abstract][Full Text] [Related]
32. A randomized, multicentre, double-blind, parallel-group study to assess the adverse event-related discontinuation rate with celecoxib and diclofenac in elderly patients with osteoarthritis.
Dahlberg LE; Holme I; Høye K; Ringertz B
Scand J Rheumatol; 2009; 38(2):133-43. PubMed ID: 19165648
[TBL] [Abstract][Full Text] [Related]
33. Gastrointestinal and cardiovascular risk of non-selective NSAIDs and COX-2 inhibitors in elderly patients with knee osteoarthritis.
Turajane T; Wongbunnak R; Patcharatrakul T; Ratansumawong K; Poigampetch Y; Songpatanasilp T
J Med Assoc Thai; 2009 Dec; 92 Suppl 6():S19-26. PubMed ID: 20128070
[TBL] [Abstract][Full Text] [Related]
34. Gastrointestinal tolerability of NSAIDs in elderly patients: a pooled analysis of 21 randomized clinical trials with celecoxib and nonselective NSAIDs.
Mallen SR; Essex MN; Zhang R
Curr Med Res Opin; 2011 Jul; 27(7):1359-66. PubMed ID: 21561397
[TBL] [Abstract][Full Text] [Related]
35. The efficacy and cost effectiveness of N of 1 studies with diclofenac compared to standard treatment with nonsteroidal antiinflammatory drugs in osteoarthritis.
Pope JE; Prashker M; Anderson J
J Rheumatol; 2004 Jan; 31(1):140-9. PubMed ID: 14705233
[TBL] [Abstract][Full Text] [Related]
36. Analgesic efficacy and safety of the diclofenac epolamine topical patch 1.3% (DETP) in minor soft tissue injury.
Kuehl K; Carr W; Yanchick J; Magelli M; Rovati S
Int J Sports Med; 2011 Aug; 32(8):635-43. PubMed ID: 21563042
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of symptomatic control of knee osteoarthritis with 0.0125% of capsaicin versus placebo.
Kosuwon W; Sirichatiwapee W; Wisanuyotin T; Jeeravipoolvarn P; Laupattarakasem W
J Med Assoc Thai; 2010 Oct; 93(10):1188-95. PubMed ID: 20973322
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of topical NSAIDs in the management of osteoarthritis: Evidence from real-life setting trials and surveys.
Rannou F; Pelletier JP; Martel-Pelletier J
Semin Arthritis Rheum; 2016 Feb; 45(4 Suppl):S18-21. PubMed ID: 26806189
[TBL] [Abstract][Full Text] [Related]
39. Multicenter, randomized, double-blind, active-controlled, parallel-group trial of the long-term (6-12 months) safety of acetaminophen in adult patients with osteoarthritis.
Temple AR; Benson GD; Zinsenheim JR; Schweinle JE
Clin Ther; 2006 Feb; 28(2):222-35. PubMed ID: 16678643
[TBL] [Abstract][Full Text] [Related]
40. Treatment of osteoarthritis of the knee with a topical diclofenac solution: a randomised controlled, 6-week trial [ISRCTN53366886].
Baer PA; Thomas LM; Shainhouse Z
BMC Musculoskelet Disord; 2005 Aug; 6():44. PubMed ID: 16086839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]